Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network-Reference-Cited by-同舟云学术

Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network

Published:2009-06-16 Issue:2 Volume:2 Page:103-111
ISSN:1868-9256
Container-title:Journal of Hematopathology
language:en
Short-container-title:J Hematopathol

Author:

Klapper Wolfram,Hoster Eva,Determann Olaf,Oschlies Ilske,van der Laak Jeroen,Berger Françoise,Bernd Heinz Wolfram,Cabeçadas José,Campo Elias,Cogliatti Sergio,Hansmann Martin Leo,Kluin Philip M.,Kodet Roman,Krivolapov Yuri A.,Loddenkemper Christoph,Stein Harald,Möller Peter,Barth Thomas E. F.,Müller-Hermelink Konrad,Rosenwald Andreas,Ott German,Pileri Stefano,Ralfkiaer Elisabeth,Rymkiewicz Grzegorz,van Krieken Johan H.,Wacker Hans Heinrich,Unterhalt Michael,Hiddemann Wolfgang,Dreyling Martin,

Publisher

Springer Science and Business Media LLC

Subject

Hematology,Histology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12308-009-0036-x.pdf

Reference22 articles.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumors of the haematopoietic and lymphoid tissues. IARC, Lyon

2. Bottcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, Hiddemann W, Unterhalt M, Dreyling M, Siebert R, Kneba M, Pott C (2008) Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Haematologica 93:551–559

3. Bottcher S, Ritgen M, Pott C, Bruggemann M, Raff T, Stilgenbauer S, Dohner H, Dreger P, Kneba M (2004) Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. Leukemia 18:1637–1645

4. Coleman KE, Brat DJ, Cotsonis GA, Lawson D, Cohen C (2006) Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance. Appl Immunohistochem Mol Morphol 14:109–114

5. de Jong D, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, Sander B, Thorns C, Campo E, Molina T, Norton A, Hagenbeek A, Horning S, Lister A, Raemaekers J, Gascoyne RD, Salles G, Weller E (2007) Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications—a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 25:805–812

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab;British Journal of Haematology;2023-10-25

2. Deep Learning to Predict the Cell Proliferation and Prognosis of Non-Small Cell Lung Cancer Based on FDG-PET/CT Images;Diagnostics;2023-09-30

3. Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression);Leukemia;2023-07-26

4. Estimating the impact of early bendamustine failure on feasibility of subsequent CAR-T cell therapy in mantle cell lymphoma;Leukemia & Lymphoma;2023-06-20

5. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review;International Journal of Molecular Sciences;2023-06-16